Opportunities Preloader

Please Wait.....

Report

Red Biotechnology Market Size, Share and Forecast Trends - Growth Analysis and Outlook Report (2026-2035)

Market Report I 2026-05-20 I 350 Pages I EMR Inc.

The red biotechnology market was valued at USD 410.54 Million in 2025, driven by innovations in biopharmaceuticals and medical treatments. The market is anticipated to grow at a CAGR of 6.20% during the forecast period of 2026-2035, with values likely to reach USD 749.20 Million by 2035.

Latest News on the Red Biotechnology Market (2026)

April 2026: Eli Lilly Acquires Kelonia Therapeutics in In Vivo Cell Therapy Push

Eli Lilly's acquisition of in vivo cell therapy developer Kelonia Therapeutics marked at least the sixth such buyout since March 2025 and the largest in total proceeds within the segment. The Wall Street Journal reported that the deal continues a near-weekly run of Lilly acquisitions, including the buyout of Ajax for its clinical-stage myelofibrosis therapy, reinforcing the centrality of cell and gene therapy assets to large-pharma pipeline strategy heading into the looming USD 170 billion patent cliff.

March 2026: Novartis-Avidity Biosciences USD 12 Billion Deal Advances Toward Close

Novartis's USD 12 billion acquisition of Avidity Biosciences advanced toward expected closing in the first half of 2026, alongside BioMarin Pharmaceutical's USD 4.8 billion buyout of Amicus Therapeutics announced 19 December 2025. As reported by Reuters, the combined dealmaking environment, supported by clearing U.S. healthcare policy overhangs and additional rate cuts, has positioned 2026 as one of the strongest investment windows for red biotechnology in recent decades according to industry analysts.

Market Size & Forecast

- Market Size in 2025: USD 410.54 Million
- Projected Market Size in 2035: USD 749.20 Million
- Compound Annual Growth Rate (CAGR) of 2026 to 2035: 6.20%

It is anticipated that the increasing awareness of chronic illness therapy and a strong pipeline of fresh therapeutic molecules will drive the global red biotechnology market .

Market Segmentation

Red biotechnology is a bio-pharmaceutical that involves the utilization of organisms to enhance health care and aid the body in fighting diseases. The global red biotechnology market is segmented into applications and end-uses.

Market Breakup by Application

- Biopharmaceutical Production
- Gene Therapy
- Pharmacogenomics
- Genetic Testing

Market Breakup by End Use

- Pharmaceutical Industry
- CMO & CRO
- Research Institutes
- Others

Market Breakup by Region

- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa

Market Analysis

Owing to the increasing demand for gene therapy , clinical research, and trials, the industry for red biotechnology is increasing. People have begun to preserve their stem cells at the moment of birth because of growing awareness, and red biotechnology makes an enormous profit in this segment. The red biotechnology market is aided by the growth of pharmaceutical companies. With the increasing number of patients suffering from cancer globally, red biotechnology applications are becoming common as it helps to understand the cause of the disease, thus, further aiding the growth of the red biotechnology market. The industry is being fuelled by the increased financing in the healthcare industry.

Competitive Landscape

The report presents a detailed analysis of the following key players in the global red biotechnology industry, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

- Pfizer Inc. (NYSE: PFE)
- Biogen Inc.
- Amgen Inc.
- AstraZeneca Plc.
- Gilead Sciences, Inc.
- F. Hoffmann-La Roche, Ltd.
- Merck KGaA
- Bristol-Myers Squibb Company
- Regeneron Pharmaceuticals Inc.
- Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter's Five Forces model.

1 Preface
2 Report Coverage - Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Red Biotechnology Market Analysis
8.1 Key Industry Highlights
8.2 Global Red Biotechnology Historical Market (2019-2025)
8.3 Global Red Biotechnology Market Forecast (2026-2035)
8.4 Global Red Biotechnology Market by Application
8.4.1 Biopharmaceutical Production
8.4.1.1 Historical Trend (2019-2025)
8.4.1.2 Forecast Trend (2026-2035)
8.4.2 Gene Therapy
8.4.2.1 Historical Trend (2019-2025)
8.4.2.2 Forecast Trend (2026-2035)
8.4.3 Pharmacogenomics
8.4.3.1 Historical Trend (2019-2025)
8.4.3.2 Forecast Trend (2026-2035)
8.4.4 Genetic Testing
8.4.4.1 Historical Trend (2019-2025)
8.4.4.2 Forecast Trend (2026-2035)
8.5 Global Red Biotechnology Market by End-use
8.5.1 Pharmaceutical Industry
8.5.1.1 Historical Trend (2019-2025)
8.5.1.2 Forecast Trend (2026-2035)
8.5.2 CMO & CRO
8.5.2.1 Historical Trend (2019-2025)
8.5.2.2 Forecast Trend (2026-2035)
8.5.3 Research Institutes
8.5.3.1 Historical Trend (2019-2025)
8.5.3.2 Forecast Trend (2026-2035)
8.5.4 Others
8.6 Global Red Biotechnology Market by Region
8.6.1 North America
8.6.1.1 Historical Trend (2019-2025)
8.6.1.2 Forecast Trend (2026-2035)
8.6.2 Europe
8.6.2.1 Historical Trend (2019-2025)
8.6.2.2 Forecast Trend (2026-2035)
8.6.3 Asia Pacific
8.6.3.1 Historical Trend (2019-2025)
8.6.3.2 Forecast Trend (2026-2035)
8.6.4 Latin America
8.6.4.1 Historical Trend (2019-2025)
8.6.4.2 Forecast Trend (2026-2035)
8.6.5 Middle East and Africa
8.6.5.1 Historical Trend (2019-2025)
8.6.5.2 Forecast Trend (2026-2035)
9 North America Red Biotechnology Market Analysis
9.1 United States of America
9.1.1 Historical Trend (2019-2025)
9.1.2 Forecast Trend (2026-2035)
9.2 Canada
9.2.1 Historical Trend (2019-2025)
9.2.2 Forecast Trend (2026-2035)
10 Europe Red Biotechnology Market Analysis
10.1 United Kingdom
10.1.1 Historical Trend (2019-2025)
10.1.2 Forecast Trend (2026-2035)
10.2 Germany
10.2.1 Historical Trend (2019-2025)
10.2.2 Forecast Trend (2026-2035)
10.3 France
10.3.1 Historical Trend (2019-2025)
10.3.2 Forecast Trend (2026-2035)
10.4 Italy
10.4.1 Historical Trend (2019-2025)
10.4.2 Forecast Trend (2026-2035)
10.5 Others
11 Asia Pacific Red Biotechnology Market Analysis
11.1 China
11.1.1 Historical Trend (2019-2025)
11.1.2 Forecast Trend (2026-2035)
11.2 Japan
11.2.1 Historical Trend (2019-2025)
11.2.2 Forecast Trend (2026-2035)
11.3 India
11.3.1 Historical Trend (2019-2025)
11.3.2 Forecast Trend (2026-2035)
11.4 ASEAN
11.4.1 Historical Trend (2019-2025)
11.4.2 Forecast Trend (2026-2035)
11.5 Australia
11.5.1 Historical Trend (2019-2025)
11.5.2 Forecast Trend (2026-2035)
11.6 Others
12 Latin America Red Biotechnology Market Analysis
12.1 Brazil
12.1.1 Historical Trend (2019-2025)
12.1.2 Forecast Trend (2026-2035)
12.2 Argentina
12.2.1 Historical Trend (2019-2025)
12.2.2 Forecast Trend (2026-2035)
12.3 Mexico
12.3.1 Historical Trend (2019-2025)
12.3.2 Forecast Trend (2026-2035)
12.4 Others
13 Middle East and Africa Red Biotechnology Market Analysis
13.1 Saudi Arabia
13.1.1 Historical Trend (2019-2025)
13.1.2 Forecast Trend (2026-2035)
13.2 United Arab Emirates
13.2.1 Historical Trend (2019-2025)
13.2.2 Forecast Trend (2026-2035)
13.3 Nigeria
13.3.1 Historical Trend (2019-2025)
13.3.2 Forecast Trend (2026-2035)
13.4 South Africa
13.4.1 Historical Trend (2019-2025)
13.4.2 Forecast Trend (2026-2035)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter's Five Forces Analysis
14.2.1 Supplier's Power
14.2.2 Buyer's Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Value Chain Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Company Profiles
16.2.1 Pfizer Inc.
16.2.1.1 Company Overview
16.2.1.2 Product Portfolio
16.2.1.3 Demographic Reach and Achievements
16.2.1.4 Certifications
16.2.2 Biogen Inc.
16.2.2.1 Company Overview
16.2.2.2 Product Portfolio
16.2.2.3 Demographic Reach and Achievements
16.2.2.4 Certifications
16.2.3 Amgen Inc.
16.2.3.1 Company Overview
16.2.3.2 Product Portfolio
16.2.3.3 Demographic Reach and Achievements
16.2.3.4 Certifications
16.2.4 Astrazeneca Plc.
16.2.4.1 Company Overview
16.2.4.2 Product Portfolio
16.2.4.3 Demographic Reach and Achievements
16.2.4.4 Certifications
16.2.5 Gilead Sciences, Inc.
16.2.5.1 Company Overview
16.2.5.2 Product Portfolio
16.2.5.3 Demographic Reach and Achievements
16.2.5.4 Certifications
16.2.6 F. Hoffmann-La Roche, Ltd.
16.2.6.1 Company Overview
16.2.6.2 Product Portfolio
16.2.6.3 Demographic Reach and Achievements
16.2.6.4 Certifications
16.2.7 Merck KGaA
16.2.7.1 Company Overview
16.2.7.2 Product Portfolio
16.2.7.3 Demographic Reach and Achievements
16.2.7.4 Certifications
16.2.8 Bristol-Myers Squibb Company
16.2.8.1 Company Overview
16.2.8.2 Product Portfolio
16.2.8.3 Demographic Reach and Achievements
16.2.8.4 Certifications
16.2.9 Regeneron Pharmaceuticals Inc.
16.2.9.1 Company Overview
16.2.9.2 Product Portfolio
16.2.9.3 Demographic Reach and Achievements
16.2.9.4 Certifications
16.2.10 Others

  • Not Sure / Need Reassuring
    • Confirm Content
      • Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:

        Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.

        Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.

        Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.

    • Sample Pages
      • With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.

        It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.

        To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Check for Alternatives
      • Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.

        To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.

  • Prices / Formats / Delivery
    • Prices
      • All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.

        Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Discounts
      • As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.

        Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.

        To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Available Currencies
      • Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.

        Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.

        To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.

    • Licenses
      • License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Global Site License
      • The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.

        It is important to note that this may exclude Parent Companies or Subsidiaries.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Formats
      • The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.

        If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.

    • Delivery
      • Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.

        Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.

        If a delay in delivery is expected you will be informed about it immediately.

    • Shipping Charges
      • As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.

        If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.

  • Ordering
    • By Credit Card
      • We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.

        Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.

        For more information on PayU please visit: https://www.payu.pl/en/about-us

    • By Money Transfer
      • If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.

        With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.

  • Security
    • Website security
      • We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.

        Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.

    • Credit Card Security
      • We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.

        PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.

PLEASE SELECT LICENSE